Expression and Prognostic Significance of HLA Class I, ICAM-1, and Tumor-Infiltrating Lymphocytes in Esophageal Cancer

Journal of Gastrointestinal Surgery

Volumn 1, Issue 4, 1997, Pages 316-323

  Hosch, Stefan B ^a   Meyer, Alexander J ^a   Schneider, Claus ^a   Stoecklein, Nikolas ^a   Prenzel, Klaus L ^a   Pantel, Klaus ^a,b   Broelsch, Christoph E ^a   Izbicki, Jakob R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010424666     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(97)80051-0     Document Type: Article

References (24)

1. Lerut T, DeLeyn P, Coosemans W, van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216:583-590.
2. Siewert JR, Bartels H, Bollschweiler E, Dittler HJ, Fink U, Hölscher AH, Roder JD. Plattenepithelcarzinom des Ösophagus. Chirurg 1992;63:693-700.
3. Watanabe H. Plattenepithelcarcinom des Oesophagus. Chirurg 1992;63:689-692.
4. Earlam R. Epidemiology of esophageal cancer from the European point of view. In Siewert JR, Hölscher AH, eds. Diseases of the Esophagus. Berlin: Springer-Verlag, 1988, pp 11-18.
5. Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B. Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial. Br J Surg 1993;80:367-370.
6. Alam SM, Clark JS, Leech V, Whitford P, George WD, Campbell AM. T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients. Immun Lett 1992;31:279-283.
7. Aoe T, Goto S, Ohno H, Saito T. Different cytoplasmic structure of the CD3 zeta family dimer modulates the activation signal and function of T cells. Int Immunol 1994;6:1671-1679.
8. Webb DSA, Mostowski HS, Gerrard TL. Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J Immunol 1991;146:3682-3686.
9. Vánky F, Wang P, Patarroyo M, Klein E. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother 1990;31:19-27.
10. Braakman E, Goedegebuure PS, Vreugdenhil RJ, Segal DM, Shaw S, Bolhuis RLH. ICAM-melanoma cells are relatively resistant to CD3-mediated T-cell lysis. Int J Cancer 1990;46: 475-480.
11. Hermanek P, Sobin LH. TNM Classification of Malignant Tumours, 4th ed. New York: Springer-Verlag, 1987, pp 42-44.
12. Anderson TM, Ibayashi Y, Holmes E, Golup SH. Modification of the natural killer cell activity of lymphocytes infiltrating human lung cancers. Cancer Immunol Immunother 1987; 22:65-68.
13. Eremin O, Coombs RRA, Ashby J. Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK cell activity. Br J Cancer 1981;44:166-167.
14. Rabinovich H, Steiner Z, Klajman A. Clonal analysis of human tumor-infiltrating lymphocytes reactive with autologous tumor cells: Different target cell specifities of NK-like and cytotoxic T-cell clones. Cell Immunol 1987;104:210-217.
15. Vose BM, Moore M. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumors. Int J Cancer 1979; 24:579-585.
16. Töttermann TH, Hävry P, Saksela E, Timonen T, Eklund B. Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. Functional investigations of the infiltrating inflammatory cells. Eur J Immunol 1978;8:872-875.
17. Burger UL, Chang MP, Goedegebuure PS, Eberlein TJ. Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancer. Surgery 1995;117:325-333.
18. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol 1993;151:4847-4856.
19. Hutchinson GH, Heinemann D, Symes MO, Williamson RCN. Differential immune reactivity of tumor-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells. Br J Cancer 1981;44:396-402.
20. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: Effect of tumor cells and their supernatants on the proliferative response of lymphocytes. J Immunol 1986;136:1899-1907.
21. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990;144:4579-4586.
22. Altmann DM, Hogg N, Trowsdale J, Wilkinson D. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 1989; 338:512-514.
23. Johnson JP, Stade BG, Holzmann B, Schwäble W, Riethmüller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci 1989;86:641-644.
24. Pardoll DM. Cancer vaccines. Immunol Today 1993;14:310-316.